GlassScriptPhysician profile
Benjamin John Borton
NPI 1740799451
$1,708.03
in general payments reported to CMS, 2019-2025
14 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $327 · 2022: $683 · 2023: $495 · 2024: $44.27 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.43 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $811.68 | 2021-2025 | Gvoke Hypopen |
| Novo Nordisk INC | $301.26 | 2021-2024 | Rybelsus, Ozempic, Saxenda |
| Astrazeneca Pharmaceuticals LP | $166.03 | 2021-2022 | |
| Medtronic, INC. | $135.30 | 2023-2025 | Minimed 780g |
| Lilly USA, LLC | $65.44 | 2022-2023 | Mounjaro, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.16 | 2021-2025 | Jardiance, Synjardy |
| Sanofi-Aventis U.S. LLC | $42.90 | 2022 | |
| Radius Health, INC. | $38.24 | 2023 | Tymlos |
| Nevro Corp. | $19.36 | 2022 | |
| Tandem Diabetes Care, INC. | $16.38 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Antares Pharma, INC. | $15.13 | 2023 | Tlando, Xyosted, Nocdurna |
| Insulet Corporation | $14.01 | 2021 | |
| Dexcom, INC. | $13.63 | 2023 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $13.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Borton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.